IS INTERFERON-A AN ACTIVE AGENT IN CASTLEMANS DISEASE

被引：17

作者：

PAVLIDIS, NA

BRIASSOULIS, E

KLOUVAS, G

BAI, M

机构：

[1] UNIV IOANNINA,DEPT MED,ONCOL SECT,GR-45110 IOANNINA,GREECE

[2] UNIV IOANNINA,DEPT PATHOL,GR-45110 IOANNINA,GREECE

来源：

ANNALS OF ONCOLOGY | 1992年 / 3卷 / 01期

关键词：

D O I：

10.1093/oxfordjournals.annonc.a058082

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：85 / 86

页数：2

共 9 条

[1]

CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO

[2]

2-4

[3] A SYSTEMIC LYMPHOPROLIFERATIVE DISORDER WITH MORPHOLOGIC FEATURES OF CASTLEMANS DISEASE - CLINICAL FINDINGS AND CLINICOPATHOLOGIC CORRELATIONS IN 15 PATIENTS [J].

FRIZZERA, G ;

PETERSON, BA ;

BAYRD, ED ;

GOLDMAN, A .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (09) :1202-1216

[4]

KESSLER E, 1985, CANCER, V56, P2466

[5] A SUCCESSFULLY TREATED CASE OF MULTICENTRIC ANGIOFOLLICULAR HYPERPLASIA WITH ORAL CHEMOTHERAPY (CASTLEMANS DISEASE) [J].

PAVLIDIS, NA ;

SKOPOULI, FN ;

BAI, MC ;

BOURANTAS, CL .

MEDICAL AND PEDIATRIC ONCOLOGY, 1990, 18 (04) :333-335

[6]

PAVLIDIS NA, 1982, J RHEUMATOL, V9, P685

[7]

PAVLIDIS NA, 1991, IN PRESS BENIGN MALI

[8]

PREZEPIORKA D, 1985, SEM ONCOLOGY S5, V15

[9] AGGRESSIVE ANGIOFOLLICULAR LYMPH-NODE HYPERPLASIA (CASTLEMANS DISEASE) TREATED WITH HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].

REPETTO, L ;

JAIPRAKASH, MP ;

SELBY, PJ ;

GUSTERSON, BA ;

WILLIAMS, HJH ;

MCELWAIN, TJ .

HEMATOLOGICAL ONCOLOGY, 1986, 4 (03) :213-217

← 1 →